Angiotensin Receptor Antagonists: all 1,100 studies that test it

Page 8 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineCompletedNCT01842230Phase 1
• Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male VolunteersCompletedNCT01831479Phase 1
• HIGH Altitude CArdiovascular REsearch in the ANDESCompletedNCT01830530Phase 4
• RAS Quantification in Patients With Aliskiren or CandesartanCompletedNCT01827202Phase 4
• Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male SubjectsCompletedNCT01825850Phase 1
• Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeCompletedNCT01819220Phase 4
• Pharmacokinetic Interactions and Safety Study of Telmisartan and ChlorthalidoneCompletedNCT01806363Phase 1
• Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaCompletedNCT01805453Phase 3
• Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting ConditionsCompletedNCT01797926Phase 1
• Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)CompletedNCT01767298Not applicable
• Pharmacokinetic Interactions of Valsartan and HydrochlorothiazideCompletedNCT01767259Not applicable
• The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)TerminatedNCT01766505Phase 4
• Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsCompletedNCT01736488Phase 4
• Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesCompletedNCT01734096Phase 4
• Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNCT01712139Not applicable
• Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable
• Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted ConditionsCompletedNCT01712113Not applicable
• Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed ConditionsCompletedNCT01712100Not applicable
• Role of Inflammation Factors and Insulin Resistance in Major Depressive DisorderStatus unknownNCT01699490Phase 4
• Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
• A Trial of Fimasartan for Early Diastolic Heart FailureCompletedNCT01691118Phase 4
• Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic AneurysmsCompletedNCT01683084Phase 4
• To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedNCT01682564Phase 4
• Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?CompletedNCT01675362Phase 4
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionCompletedNCT01672476Phase 3
• Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy SubjectsCompletedNCT01671020Phase 1
• Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCompletedNCT01625494Phase 3
• Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension TreatmentSuspendedNCT01620788Phase 3
• Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCompletedNCT01611077Phase 4
• New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure LoweringCompletedNCT01609959Phase 4
• Pharmacokinetic Drug Interaction Between Rosuvastatin and ValsartanCompletedNCT01609907Phase 1
• A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)Status unknownNCT01589380Phase 4
• Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in HumanCompletedNCT01570569Phase 1
• The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on ProteinuriaCompletedNCT01541267Phase 4
• Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.CompletedNCT01541189Phase 4
• Preeclampsia: A Marker for Future Cardiovascular Risk in WomenSuspendedNCT01519297Not applicable
• Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic CardiomyopathyCompletedNCT01447654Phase 2
• Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric PatientsCompletedNCT01447485Phase 1
• Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) BlockerStatus unknownNCT01444833Not applicable
• Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AFCompletedNCT01435161Phase 4
• Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer TherapyCompletedNCT01434134Phase 2
• The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic SyndromeWithdrawnNCT01432106Phase 1
• Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular HypertrophyCompletedNCT01425411Phase 4
• Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionCompletedNCT01415505Phase 3
• Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersCompletedNCT01415466Phase 1
• Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy SubjectsCompletedNCT01406431Phase 1
• Blood Pressure Lowering in Acute Stroke TrialWithdrawnNCT01400256Phase 4
• Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)TerminatedNCT01384747Phase 4
• Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)Status unknownNCT01377285Phase 4
• CKD-828 Drug Interaction Study (Telmisartan)CompletedNCT01356017Phase 1
• Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCompletedNCT01350609Phase 1
• Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene MutationsStatus unknownNCT01320397Phase 2
• The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01305850Phase 4
• Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedNCT01303783Phase 2
• Contribution of Angiotensin II to Supine Hypertension in Autonomic FailureTerminatedNCT01292694Phase 1
• Fimasartan (BR-A-657) Multiple Oral Dose in Healthy SubjectsCompletedNCT01289899Phase 1
• Fimasartan (BR-A-657) Single Oral Dose in Healthy SubjectsCompletedNCT01289886Phase 1
• Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedNCT01289132Phase 2
• PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung CancerCompletedNCT01281787Phase 3
• Use of Telmisartan and Captopril in Inflammation of Hemodialysis PatientsCompletedNCT01271478Phase 4
• Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeStatus unknownNCT01271374Phase 4
• A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCompletedNCT01241487Phase 4
• Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)CompletedNCT01232049Phase 1
• Telmisartan Versus Losartan in Kidney TransplantationCompletedNCT01224860Phase 2
• Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed ConditionsCompletedNCT01218724Phase 1
• Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.CompletedNCT01218711Phase 1
• Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed ConditionCompletedNCT01218698Phase 1
• Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting ConditionCompletedNCT01218022Phase 1
• Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed ConditionsCompletedNCT01216878Not applicable
• Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsCompletedNCT01216852Not applicable
• Local Vasoconstriction in Postural Tachycardia SyndromeCompletedNCT01210430Early Phase 1
• Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular SchwannomaActive, not recruitingNCT01199978Phase 2
• Recurrent Stroke Prevention Clinical Outcome StudyStatus unknownNCT01198496Phase 4
• A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197014Phase 1
• A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCompletedNCT01197001Phase 1
• Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of CytochromesCompletedNCT01187862Phase 1
• Intensive Vasodilator Therapy in Patients With Essential HypertensionCompletedNCT01180413Phase 4
• Telmisartan, Amlodipine and Flow Mediated DilationStatus unknownNCT01180205Phase 4
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy VolunteersCompletedNCT01148368Phase 1
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNCT01146938Phase 1
• Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan SyndromeStatus unknownNCT01145612Phase 3
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
• The Confirmatory Olmesartan Plaque Regression StudyTerminatedNCT01132768Phase 4
• CKD-828 Primary Hypertension Trial(Dose-selection)CompletedNCT01128322Phase 2
• Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 HypertensionCompletedNCT01127217Phase 3
• Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential HypertensionCompletedNCT01122251Phase 2
• Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemCompletedNCT01116180Not applicable
• A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy VolunteersCompletedNCT01115972Phase 1
• Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted ConditionsCompletedNCT01102478Not applicable
• Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed ConditionsCompletedNCT01102465Not applicable
• Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive DiabeticsStatus unknownNCT01095822Phase 4
• Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyWithdrawnNCT01089452Phase 4
• Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy VolunteersCompletedNCT01087749Phase 1
• A Trial of Telmisartan Prevention of Cardiovascular DiseaseCompletedNCT01075698Phase 4
• FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)CompletedNCT01071122Phase 4
• An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedNCT01062451Phase 1
• Anti-Fibrotic Effects of Losartan In Nash Evaluation StudyCompletedNCT01051219Phase 3
• The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis PatientsStatus unknownNCT01041963Phase 4
• Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)CompletedNCT01028534Not applicable
• Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4

← Angiotensin Receptor Antagonists overview